This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Walker, G. E. Articles by Oh, Y. Search for Related Content PubMed PubMed Citation Articles by Walker, G. E. Articles by Oh, Y.

Butyrate, a Histone Deacetylase Inhibitor, Activates the Human IGF Binding Protein-3 Promoter in Breast Cancer Cells: Molecular Mechanism Involves an Sp1/Sp3 Multiprotein Complex

Department of Pediatrics (G.E.W., E.M.W., Y.O.), Oregon Health Sciences University, Portland, Oregon 97201; and Baylor College of Medicine (D.P.), Houston, Texas 77030

Address all correspondence and requests for reprints to: Youngman Oh, Ph.D., Department of Pediatrics, Oregon Health Sciences University, 3181 SW Sam Jackson Park Road, Portland, Oregon 97201. E-mail: ohy{at}ohsu.edu

Specific cell growth stimulators and inhibitors regulate IGF binding protein-3 (IGFBP-3), where in turn IGFBP-3 mediates their biological effects. The molecular mechanism(s) by which these factors regulate IGFBP-3 are unknown. Sodium butyrate, a histone deacetylase inhibitor causing growth arrest and differentiation, increases IGFBP-3 expression. We investigated the molecular mechanism of this induction using an IGFBP-3 promoter reporter system in MCF-7 and Hs578T breast cancer cells. IGFBP-3 promoter activity was induced up to 40-fold following a 24-h treatment with sodium butyrate and 46-fold in cells treated with trichostatin A, a pure histone deacetylase inhibitor. Deletion analysis of the IGFBP-3 promoter identified key sodium butyrate-responsive element(s) to a 45-bp region containing consensus binding sites for Sp1 and activating protein-2. Sp1 binding to the Sp1 site and Sp3 to the activating protein-2/GA-box played a functional role in sodium butyrate’s activation of the IGFBP-3 promoter, however, with no change in binding direct sodium butyrate regulation was attributed to cofactors. The histone acetyltransferase p300 and histone deacetylase-1 were identified in multiprotein complexes containing DNA bound Sp1 and Sp3, with p300 accumulating following sodium butyrate treatment. Taken together, these data suggest that sodium butyrate increases IGFBP-3 expression by activating the IGFBP-3 promoter via an Sp1/Sp3 multiprotein complex, a mechanism that may be important for other key regulators of IGFBP-3.

This article has been cited by other articles:

				J. Paquette, B. Bessette, E. Ledru, and C. Deal Identification of Upstream Stimulatory Factor Binding Sites in the Human IGFBP3 Promoter and Potential Implication of Adjacent Single-Nucleotide Polymorphisms and Responsiveness to Insulin Endocrinology, December 1, 2007; 148(12): 6007 - 6018. [Abstract] [Full Text] [PDF]

				Md. R. Amin, P. K. Dudeja, K. Ramaswamy, and J. Malakooti Involvement of Sp1 and Sp3 in differential regulation of human NHE3 promoter activity by sodium butyrate and IFN-{gamma}/TNF-{alpha} Am J Physiol Gastrointest Liver Physiol, July 1, 2007; 293(1): G374 - G382. [Abstract] [Full Text] [PDF]

				P. R. Kiela, N. Kuscuoglu, A. J. Midura, M. T. Midura-Kiela, C. B. Larmonier, M. Lipko, and F. K. Ghishan Molecular mechanism of rat NHE3 gene promoter regulation by sodium butyrate Am J Physiol Cell Physiol, July 1, 2007; 293(1): C64 - C74. [Abstract] [Full Text] [PDF]

				J. Sangerman, M. S. Lee, X. Yao, E. Oteng, C.-H. Hsiao, W. Li, S. Zein, S. F. Ofori-Acquah, and B. S. Pace Mechanism for fetal hemoglobin induction by histone deacetylase inhibitors involves {gamma}-globin activation by CREB1 and ATF-2 Blood, November 15, 2006; 108(10): 3590 - 3599. [Abstract] [Full Text] [PDF]

				Y. Zhang, M. Liao, and M. L. Dufau Phosphatidylinositol 3-Kinase/Protein Kinase C{zeta}-Induced Phosphorylation of Sp1 and p107 Repressor Release Have a Critical Role in Histone Deacetylase Inhibitor-Mediated Depression of Transcription of the Luteinizing Hormone Receptor Gene. Mol. Cell. Biol., September 1, 2006; 26(18): 6748 - 6761. [Abstract] [Full Text] [PDF]

				M. Takaoka, C. E. Smith, M. K. Mashiba, T. Okawa, C. D. Andl, W. S. El-Deiry, and H. Nakagawa EGF-mediated regulation of IGFBP-3 determines esophageal epithelial cellular response to IGF-I Am J Physiol Gastrointest Liver Physiol, February 1, 2006; 290(2): G404 - G416. [Abstract] [Full Text] [PDF]

				S.-H. Oh, W.-Y. Kim, J.-H. Kim, M. N. Younes, A. K. El-Naggar, J. N. Myers, M. Kies, P. Cohen, F. Khuri, W. K. Hong, et al. Identification of Insulin-Like Growth Factor Binding Protein-3 as a Farnesyl Transferase Inhibitor SCH66336-Induced Negative Regulator of Angiogenesis in Head and Neck Squamous Cell Carcinoma Clin. Cancer Res., January 15, 2006; 12(2): 653 - 661. [Abstract] [Full Text] [PDF]

				E. M. Ongeri, M. F. Verderame, and J. M. Hammond Follicle-Stimulating Hormone Induction of Ovarian Insulin-Like Growth Factor-Binding Protein-3 Transcription Requires a TATA Box-Binding Protein and the Protein Kinase A and Phosphatidylinositol-3 Kinase Pathways Mol. Endocrinol., July 1, 2005; 19(7): 1837 - 1848. [Abstract] [Full Text] [PDF]

				W. Huang, S. Zhao, S. Ammanamanchi, M. Brattain, K. Venkatasubbarao, and J. W. Freeman Trichostatin A Induces Transforming Growth Factor {beta} Type II Receptor Promoter Activity and Acetylation of Sp1 by Recruitment of PCAF/p300 to a Sp1{middle dot}NF-Y Complex J. Biol. Chem., March 18, 2005; 280(11): 10047 - 10054. [Abstract] [Full Text] [PDF]

				J. B. Griffin, R. Rodriguez-Melendez, and J. Zempleni The Nuclear Abundance of Transcription Factors Sp1 and Sp3 Depends on Biotin in Jurkat Cells J. Nutr., November 1, 2003; 133(11): 3409 - 3415. [Abstract] [Full Text] [PDF]

				C. Kavanaugh and J. E. Green The Use of Genetically Altered Mice for Breast Cancer Prevention Studies J. Nutr., July 1, 2003; 133(7): 2404S - 2409. [Abstract] [Full Text] [PDF]

				J. R. Davie Inhibition of Histone Deacetylase Activity by Butyrate J. Nutr., July 1, 2003; 133(7): 2485S - 2493. [Abstract] [Full Text] [PDF]

				S. Zhao, K. Venkatasubbarao, S. Li, and J. W. Freeman Requirement of a Specific Sp1 Site for Histone Deacetylase-mediated Repression of Transforming Growth Factor {beta} Type II Receptor Expression in Human Pancreatic Cancer Cells Cancer Res., May 15, 2003; 63(10): 2624 - 2630. [Abstract] [Full Text] [PDF]

				D. B. Buxton, E. Golomb, and R. S. Adelstein Induction of Nonmuscle Myosin Heavy Chain II-C by Butyrate in RAW 264.7 Mouse Macrophages J. Biol. Chem., April 18, 2003; 278(17): 15449 - 15455. [Abstract] [Full Text] [PDF]

				N. Camarero, A. Nadal, M. J. Barrero, D. Haro, and P. F. Marrero Histone deacetylase inhibitors stimulate mitochondrial HMG-CoA synthase gene expression via a promoter proximal Sp1 site Nucleic Acids Res., March 15, 2003; 31(6): 1693 - 1703. [Abstract] [Full Text] [PDF]

				T.J. Collard, M. Guy, A.J. Butt, C.M. Perks, J.M.P. Holly, C. Paraskeva, and A.C. Williams Transcriptional upregulation of the insulin-like growth factor binding protein IGFBP-3 by sodium butyrate increases IGF-independent apoptosis in human colonic adenoma-derived epithelial cells Carcinogenesis, March 1, 2003; 24(3): 393 - 401. [Abstract] [Full Text] [PDF]

				S. M. Firth and R. C. Baxter Cellular Actions of the Insulin-Like Growth Factor Binding Proteins Endocr. Rev., December 1, 2002; 23(6): 824 - 854. [Abstract] [Full Text] [PDF]

				Y. S. Chang, K. Gong, S. Sun, D. Liu, A. K. El-Naggar, F. R. Khuri, W. K. Hong, and H.-Y. Lee Clinical Significance of Insulin-like Growth Factor-binding Protein-3 Expression in Stage I Non-Small Cell Lung Cancer Clin. Cancer Res., December 1, 2002; 8(12): 3796 - 3802. [Abstract] [Full Text] [PDF]

				J. Won, J. Yim, and T. K. Kim Sp1 and Sp3 Recruit Histone Deacetylase to Repress Transcription of Human Telomerase Reverse Transcriptase (hTERT) Promoter in Normal Human Somatic Cells J. Biol. Chem., October 4, 2002; 277(41): 38230 - 38238. [Abstract] [Full Text] [PDF]

				J. Tsubaki, V. Hwa, S. M. Twigg, and R. G. Rosenfeld Differential Activation of the IGF Binding Protein-3 Promoter by Butyrate in Prostate Cancer Cells Endocrinology, May 1, 2002; 143(5): 1778 - 1788. [Abstract] [Full Text] [PDF]